Market Overview

Options Brief: Keryx Biopharmaceuticals, Inc (KERX)


Shares of Keryx Biopharmaceuticals, Inc (NASDAQ: KERX) are higher on the session by 6.70%, trading at $4.62.

Overall call volume is now running at 2.31x the daily average, with 67% of all calls traded being purchases on the offer. 1,245 contracts have traded on the session so far.

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.

Posted-In: Options


Related Articles (KERX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→